Prevalence of Severe Neurocognitive Impairment and Its Association with Socio-Demographics and Functionality Among Ugandan Older Persons: A Hospital-Based Study.
Barthel Index
Mini-Mental Status Examination
Ugandan elderly
dementia
early diagnosis
functionality
neurocognitive disorder
prevalence and associated factors
Journal
Clinical interventions in aging
ISSN: 1178-1998
Titre abrégé: Clin Interv Aging
Pays: New Zealand
ID NLM: 101273480
Informations de publication
Date de publication:
2021
2021
Historique:
received:
12
05
2021
accepted:
30
06
2021
entrez:
30
7
2021
pubmed:
31
7
2021
medline:
5
10
2021
Statut:
epublish
Résumé
The prevalence of neurocognitive disorders, especially dementia, is rising due to an increase in longevity. Early detection and diagnosis of neurocognitive impairments are important for early interventions and appropriate management of reversible causes, especially by the primary health workers. However, this study aimed to determine the prevalence and associated factors of severe neurocognitive impairment among elderly persons attending a tertiary hospital in Uganda. This cross-sectional survey was conducted in a Ugandan hospital setting, where older adults go for treatment for their chronic health problems. Following the inclusion criteria, interviews were conducted, where information about socio-demographics was collected, whereas neurocognitive impairment and functionality were assessed by Mini-Mental State Examination and Barthel Index, respectively. Chi-square test, Pearson correlation test, and logistic regression were performed to determine the factors associated with severe neurocognitive impairment. A total of 507 elderly persons aged 60 years and above were enrolled in this study (mean age 68.62 ±7.95 years), and the prevalence of severe neurocognitive impairment was 28.01%. Advanced age, female gender, lower education level, and functional dependency were significantly associated with severe neurocognitive impairment. Severe neurocognitive impairment is prevalent among Ugandan hospital attending elderlies with functional dependency. This suggests a need to routinely screen cognitive disorders among older persons who visit the healthcare facilities with other physical complaints to enable early detection and treatment of reversible causes of neurocognitive impairment, such as depression and delirium to enable better functionality.
Sections du résumé
BACKGROUND
BACKGROUND
The prevalence of neurocognitive disorders, especially dementia, is rising due to an increase in longevity. Early detection and diagnosis of neurocognitive impairments are important for early interventions and appropriate management of reversible causes, especially by the primary health workers. However, this study aimed to determine the prevalence and associated factors of severe neurocognitive impairment among elderly persons attending a tertiary hospital in Uganda.
METHODS
METHODS
This cross-sectional survey was conducted in a Ugandan hospital setting, where older adults go for treatment for their chronic health problems. Following the inclusion criteria, interviews were conducted, where information about socio-demographics was collected, whereas neurocognitive impairment and functionality were assessed by Mini-Mental State Examination and Barthel Index, respectively. Chi-square test, Pearson correlation test, and logistic regression were performed to determine the factors associated with severe neurocognitive impairment.
RESULTS
RESULTS
A total of 507 elderly persons aged 60 years and above were enrolled in this study (mean age 68.62 ±7.95 years), and the prevalence of severe neurocognitive impairment was 28.01%. Advanced age, female gender, lower education level, and functional dependency were significantly associated with severe neurocognitive impairment.
CONCLUSION
CONCLUSIONS
Severe neurocognitive impairment is prevalent among Ugandan hospital attending elderlies with functional dependency. This suggests a need to routinely screen cognitive disorders among older persons who visit the healthcare facilities with other physical complaints to enable early detection and treatment of reversible causes of neurocognitive impairment, such as depression and delirium to enable better functionality.
Identifiants
pubmed: 34326633
doi: 10.2147/CIA.S319891
pii: 319891
pmc: PMC8314681
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1415-1425Informations de copyright
© 2021 Atim et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest in this work.
Références
Aging Ment Health. 2021 Mar;25(3):535-542
pubmed: 31870177
Curr Alzheimer Res. 2020;17(7):680-686
pubmed: 32811414
Int Psychogeriatr. 2023 Jul;35(7):361-371
pubmed: 31647053
Int J Geriatr Psychiatry. 2013 Jul;28(7):728-37
pubmed: 22996739
Int J Geriatr Psychiatry. 2021 Jun;36(6):950-959
pubmed: 33480089
Degener Neurol Neuromuscul Dis. 2019 Dec 24;9:123-130
pubmed: 31920420
J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):216-223
pubmed: 30865184
Hisp Health Care Int. 2020 Sep;18(3):163-173
pubmed: 32126826
Psychiatr Times. 2018 Nov;35(11):14-17
pubmed: 30820070
Alzheimers Res Ther. 2020 Jan 6;12(1):9
pubmed: 31907068
Gerontologist. 1997 Jun;37(3):355-64
pubmed: 9203759
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Can J Rural Med. 2016 Summer;21(3):73-9
pubmed: 27386914
Ann Intern Med. 2014 Jun 3;160(11):791-7
pubmed: 24663815
Lancet Neurol. 2019 Jan;18(1):88-106
pubmed: 30497964
Metab Brain Dis. 2014 Jun;29(2):261-8
pubmed: 24515303
Afr Health Sci. 2013 Mar;13(1):87-93
pubmed: 23658573
Neurobiol Aging. 2001 Jul-Aug;22(4):575-80
pubmed: 11445258
Int J Equity Health. 2015 Mar 07;14:26
pubmed: 25889558
J Aging Stud. 2018 Jun;45:25-31
pubmed: 29735206
J Assoc Nurses AIDS Care. 2019 Sep-Oct;30(5):531-538
pubmed: 31461736
Drugs Aging. 1999 Nov;15(5):365-75
pubmed: 10600044
BMC Health Serv Res. 2019 Dec 27;19(1):1005
pubmed: 31881885
Clin Interv Aging. 2020 Nov 13;15:2183-2194
pubmed: 33223824
Int J Alzheimers Dis. 2014;2014:195750
pubmed: 25177512
J Alzheimers Dis. 2016 Apr 12;52(3):967-74
pubmed: 27079702
BMC Geriatr. 2020 Feb 10;20(1):48
pubmed: 32041525
Neurobiol Dis. 2019 Oct;130:104481
pubmed: 31136814
J Gerontol A Biol Sci Med Sci. 2017 Feb;72(2):251-258
pubmed: 27129917
Aging Ment Health. 2021 May;25(5):832-843
pubmed: 32091238
Neuroepidemiology. 2012;38(3):130-7
pubmed: 22433971
BMJ. 1995 Apr 15;310(6985):951-2
pubmed: 7728017
J Neurovirol. 2019 Dec;25(6):800-813
pubmed: 31218522
Eur J Pharmacol. 2008 May 6;585(1):97-108
pubmed: 18395201
J Alzheimers Dis. 2015;45(1):117-26
pubmed: 25471192
J Am Geriatr Soc. 1992 Sep;40(9):922-35
pubmed: 1512391
Aust N Z J Psychiatry. 2010 Oct;44(10):888-93
pubmed: 20932202
Age Ageing. 2016 Jul;45(4):523-8
pubmed: 27055879
BMC Geriatr. 2020 Apr 15;20(1):135
pubmed: 32293301
Alzheimer Dis Assoc Disord. 2011 Oct-Dec;25(4):289-304
pubmed: 21750453
Lancet Glob Health. 2019 Jul;7(7):e883-e892
pubmed: 31129125
Front Psychiatry. 2020 May 08;11:282
pubmed: 32457659
J Neurovirol. 2019 Jun;25(3):410-414
pubmed: 30671778
Cerebrovasc Dis. 2002;13 Suppl 2:7-10
pubmed: 11901236
BMC Neurol. 2018 Oct 3;18(1):163
pubmed: 30285663
Health Soc Care Community. 2019 May;27(3):642-653
pubmed: 30402986